Cancer research is one of the most demanding and time consuming industries in the world. The job requires for long hours of due diligence and testing. Cancer is no joke and the medications that are being developed to fight this disease, can’t be left up to chance. Dr. Clay Siegall is all too familiar with the process as he has done this very thing time and time again. Siegall is the president and founder of Seattle Genetics, which is one of the top biotech companies on earth. Seattle Genetics focuses on developing and commercializing antibody-based therapies.
These powerful medications are much more efficient when it comes to destroying cancer. Unlike the eras of the past, antibody-based therapies are easier on the body, and it won’t make the patient sick. This is a huge bonus since most cancer medications can make the patient feel even more ill than the illness itself. Siegall’s thorough approach to how the medications are developed and delivered, ensures the patients that they’re receiving the best products to help themselves get better. These types of therapies are known as antibody-drug conjugates, and they’re yielding much better results than previous cancer medications.
Siegall does a good job of informing the public of any breakthroughs and upcoming events through blogging. Of course, he’s a very busy man, but he still seems to find time to announce this valuable information. Some of his latest blogs spoke a wide variety of topics such as politics, sports and science.
Rigorous research is one of the key factors that goes into producing high quality medications and Seattle Genetics is no exception. With so many more already in the company’s pipeline, who knows what the next wave of antibody-drug conjugates will do.